Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 1
Submit an article Journal homepage
2,812
Views
7
CrossRef citations to date
0
Altmetric
Coronaviruses

Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai

Qianhui Wua School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, People’s Republic of ChinaView further author information
,
Hongyu Wangb Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Jianpeng Caib Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Jingwen Aib Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Yang Lib Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Haocheng Zhangb Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Sen Wangb Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Feng Sunb Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Yanpeng Wua School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, People’s Republic of ChinaView further author information
,
Jiaxin Zhoua School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, People’s Republic of ChinaView further author information
,
Yan Wanga School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, People’s Republic of ChinaView further author information
,
Hongjie Yua School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, People’s Republic of China;b Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Wenhong Zhangb Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of China;c Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;d State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, People’s Republic of China;e National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: e2169197 | Received 21 Nov 2022, Accepted 11 Jan 2023, Published online: 27 Jan 2023

References

  • Chen Z, Deng X, Fang L, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Lancet Reg Health West Pac. 2022;29:100592.
  • McMenamin ME, Nealon J, Lin Y, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022;22(10):1435–1443.
  • Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399(10340):2011–2012.
  • Commission CNH. Diagnosis and treatment protocol for COVID-19 (trial version 8). 2021. [cited Oct 25 2022]. http://www.gov.cn/zhengce/zhengceku/2021-04/15/content_5599795.htm.
  • Commission CNH. Diagnosis and treatment protocol for COVID-19 (Trial Version 9). 2022. [cited Oct 25 2022]. http://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.htm.
  • Yang B, Wong IOL, Xiao J, et al. Effectiveness of CoronaVac and BNT162b2 Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Infections in Hong Kong. J Infect Dis. 2022;226(8):1382–1384.
  • Huang Z, Xu S, Liu J, et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 omicron BA. 2 variant infection, severe illness, and death. BMC Med. 2022;20(1):400.
  • Wang Q, Guo Y, Iketani S, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608(7923):603–608.
  • Cao Y, Yisimayi A, Jian F, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593–602.
  • Tseng HF, Ackerson B, Bruxvoort K, et al. Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. medRxiv. 2022. https://doi.org/10.1101/2022.09.30.22280573
  • Surie D, Bonnell L, Adams K, et al. Effectiveness of monovalent mRNA vaccines against COVID-19-associated hospitalization among immunocompetent adults during BA.1/BA.2 and BA.4/BA.5 predominant periods of SARS-CoV-2 Omicron variant in the United States – IVY network, 18 states, December 26, 2021–August 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(42):1327–1334.
  • Shanghai Municipal Peoples Government. COVID-19 vaccine coverage of the elderly reached 70.14% as of July 24. 2022. [cited Oct 25 2022]. http://service.shanghai.gov.cn/SHVideo/newvideoshow.aspx?id=F91582A2225BAD75.
  • Agrawal U, Bedston S, McCowan C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022;400(10360):1305–1320.
  • Lance R, Dan W, Zundong Y, et al. Vaccinate with confidence and finish strong. China CDC Weekly. 2022;4(37):828–831.
  • Mao T, Israelow B, Peña-Hernández MA, et al. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science (New York, N.Y.). 2022;78(6622):eabo2523.
  • Havervall S, Marking U, Svensson J, et al. Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection. N Engl J Med. 2022;387(14):1333–1336.
  • Wang Q, Bowen A, Valdez R, et al. Antibody responses to omicron BA.1 4/BA.5 bivalent mRNA vaccine booster shot. bioRxiv. 2022. https://doi.org/10.1101/2022.10.22.513349
  • Grewal R, Kitchen SA, Nguyen L, et al. Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study. Br Med J. 2022;378:e071502.
  • Gazit S, Saciuk Y, Perez G, et al. Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study. Br Med J. 2022;377:e071113.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.